Loading
Indivior PLC Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest was filed 07 Jan 2026.
Indivior PLC: what insiders have been doing
Indivior PLC is a listed company. Filings by its managers are published through RNS (LSE). In the past year (18 October 2025 to 18 October 2026), 5 filings came from 5 insiders.
Every open-market trade in the period is a purchase: 5 purchases worth €147k, from 5 insiders, and not a single sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 5 senior executives. The largest single trade was a purchase of €54k by Wheadon David E., published on 7 January 2026.
In all, 5 purchases were made within 30 days of a purchase by another insider of the company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The latest purchase dates back some time: it was published 284 days ago, on 7 January 2026. The median gap between a trade and its publication by RNS (LSE) is 2 days. For comparison, UK MAR gives managers three business days to notify a trade.
Across the 834 companies tracked on its exchange, the median is 6 filings; at 5 filings, this issuer sits below that mark. Since 2023, the database holds 36 purchases and 12 sales by insiders of the company.
These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Insider Decl.
85
Thresholds
n/a
Buy Volume
€3M
36 ops. · all time
Sell Volume
€16M
12 ops. · all time
Who traded when
BuySaleJuliet Thompson2 buys
Keith Humphreys2 buys
Mark Stejbach2 buys
Robert A. Schriesheim2 buys
Timothy Thompson2 buys
Barbara Ryan1 buy
+7 other insiders
Analyst consensus: bullish or bearish?
Analysts rate Indivior PLC Strong Buy (bullish), based on 6 analysts. Average price target: US$50.83.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 8,028 of 24,148 companies
59.9
score / 100
Value40
Quality80
FCF yld-2.0%
Earn yld4.4%
EV/EBITDA16.9x
ROE·
Gross mgn80%
Net mgn17%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$40.53
Analyst consensus
6 analystsStrong buy
US$46.00Target US$50.83(+25%)US$59.00
Income statement
RevenueUS$1.2B
Gross profitUS$993M80% margin
EBITDAUS$304M25% margin
Net incomeUS$210M19.5% margin
Valuation
PER (trailing)20.8x
PER (forward)9.7x
Beta1.15
Balance sheet & cash
Market capUS$4.8B
Total debtUS$351M
Free Cash Flow-US$94M
Profitability & ownership
ROA22.6%
% insiders2.0%
% institutions109.5%
Last declaration on 7 January 2026
Declarations85 total
775 shares@ US$35.3926100.0% of flowOrdinary SharesSEC:0002014900-26-000004:0
Canonical exit: 5 Apr 2026 (T+90)
775 shares@ US$35.3926100.0% of flowOrdinary SharesSEC:0001827169-26-000004:0
Canonical exit: 5 Apr 2026 (T+90)
775 shares@ US$35.3926100.0% of flowOrdinary SharesSEC:0001487937-26-000004:0
Canonical exit: 5 Apr 2026 (T+90)
775 shares@ US$35.3926100.0% of flowOrdinary SharesSEC:0001257599-26-000004:0
Canonical exit: 5 Apr 2026 (T+90)
1,771 shares@ US$35.3926100.0% of flowOrdinary SharesSEC:0001789507-26-000004:0
Canonical exit: 5 Apr 2026 (T+90)
1,925 shares@ £13.8834.1% of flowNasdaq Global Select MarketISIN GB00BN4HT335RNS:5695111-0
Canonical exit: 11 Sept 2025 (T+90)
3,850 shares@ £13.8850.9% of flowNasdaq Global Select MarketISIN GB00BN4HT335RNS:5695111-1
Canonical exit: 11 Sept 2025 (T+90)
1,925 shares@ £13.8834.1% of flowNasdaq Global Select MarketISIN GB00BN4HT335RNS:5694058-0
Canonical exit: 10 Sept 2025 (T+90)
1,925 shares@ £13.8825.4% of flowNasdaq Global Select MarketISIN GB00BN4HT335RNS:5694058-1
Canonical exit: 10 Sept 2025 (T+90)
1,689,207 sharesOutside a trading venueISIN GB00BN4HT335RNS:5656289
1,000 shares@ £12.0012.0% of flowNasdaq Global Select MarketISIN GB00BN4HT335RNS:5642844
Canonical exit: 4 Aug 2025 (T+90)
14,335 sharesOutside a trading venueISIN GB00BN4HT335RNS:5577223
9,375 sharesOutside a trading venue.ISIN GB00BN4HT335RNS:5575458
243,282 sharesOutside a trading venueISIN GB00BN4HT335RNS:5569739
1,500 shares@ £9.1493100.0% of flowNasdaq Global Select MarketISIN GB00BN4HT335RNS:5569463
Canonical exit: 9 Jun 2025 (T+90)
189,125 sharesOutside a trading venueISIN GB00BN4HT335RNS:5568240-6
234,865 sharesOutside a trading venueISIN GB00BN4HT335RNS:5568240-4
327,832 sharesOutside a trading venueISIN GB00BN4HT335RNS:5568240-5
224,854 sharesOutside a trading venueISIN GB00BN4HT335RNS:5568240-3
274,291 sharesOutside a trading venueISIN GB00BN4HT335RNS:5568240-2
239,144 sharesOutside a trading venueISIN GB00BN4HT335RNS:5568240-0
189,129 sharesOutside a trading venueISIN GB00BN4HT335RNS:5568240-1
2,262 shares@ £8.8717.7% of flowNasdaq Global Select MarketISIN GB00BN4HT335RNS:5562528-0
Canonical exit: 3 Jun 2025 (T+90)
1,261 shares@ £7.01100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BN4HT335RNS:5562528-1
Canonical exit: 3 Jun 2025 (T+90)
2,764 sharesOutside a trading venueISIN GB00BN4HT335RNS:5560513-0
25 of 85 declarations
About Indivior PLC
Indivior PLC is a pharmaceutical company focused on the treatment of substance use disorders. It is listed on the London Stock Exchange under the ticker INDV.
